Resqunit (RESQ) H1 2024 earnings summary

Executive summary

• Transitioned strategic focus from environmental fishing tech to health and life sciences, targeting equity investments in listed companies within this sector since March 2024.

• Production relocated from China to Portugal to improve efficiency and reduce costs, but market adoption lagged, impacting sales and financial resources.

• Resqunit Canada Inc. was liquidated in February 2024; group assets now consist solely of shares in Resqunit AS.

Financial highlights

• Net sales for H1-2024 were SEK 573,046, nearly flat compared to SEK 587,982 in H1-2023.

• Operating profit improved to SEK -3,346,063 from SEK -4,558,675 year-over-year, mainly due to lower personnel expenses.

• Earnings per share improved to SEK -0.24 from SEK -0.43 year-over-year.

• Profit after tax was SEK -4,019,000, an improvement of SEK 742,000 compared to H1-2023.

• Cash flow from operating activities improved to SEK -2,831,000 from SEK -4,723,000 year-over-year.

Outlook and guidance

• Strategic pivot to health and life sciences sector, leveraging new expertise and partnerships, with a focus on long-term equity investments in innovative listed companies.

• Management expects this shift to better leverage company strengths and create shareholder value.